Xilio Therapeutics, Inc.
NASDAQ:XLO
1.31 (USD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -0.076 | -88.222 | -75.8 | -55.219 | -17.311 |
| Depreciation & Amortization
| 0.002 | 1.847 | 1.499 | 1.065 | 0.24 |
| Deferred Income Tax
| 2.063 | 0 | 0.222 | 0.126 | -1.737 |
| Stock Based Compensation
| 0.007 | 8.424 | 4.958 | 1.296 | 0.112 |
| Change In Working Capital
| 0 | 2.004 | -11.803 | 16.602 | 0.797 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -2.063 | 0.485 | -2.818 | 2.926 | 0.97 |
| Other Working Capital
| 0 | 1.519 | -8.985 | 13.676 | -0.173 |
| Other Non Cash Items
| -0.002 | 0.224 | 0.173 | 0.039 | 0.056 |
| Operating Cash Flow
| -0.069 | -75.723 | -80.751 | -36.091 | -17.843 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0 | -1.867 | -1.1 | -2.188 | -0.715 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -0 | -1.867 | -1.1 | -2.188 | -0.715 |
| Financing Activities: | |||||
| Debt Repayment
| -0.007 | -0.085 | -1.085 | -0.099 | -0.19 |
| Common Stock Issued
| 0.202 | 0.016 | 116.359 | 10.128 | 60.02 |
| Common Stock Repurchased
| 0.194 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | -0 | 145.394 | 0.01 | 0.19 |
| Financing Cash Flow
| -0.007 | -0.069 | 260.668 | 10.029 | 60.02 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| -0.025 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -0.076 | -77.659 | 178.817 | -28.25 | 41.462 |
| Cash At End Of Period
| 0.046 | 121.947 | 199.606 | 20.789 | 49.039 |